David Mott - Insider Trading & Ownership

Entity
Individual
Location
1119 St. Paul Street, Baltimore, MD
Summary
The estimated net worth of David Mott is at least $12.9M dollars as of November 14, 2024. David Mott is the Director of ARDELYX, INC. and owns shares of ARDELYX, INC. (ARDX) stock worth about $6.67M. David Mott is the Director of IMARA Inc. and owns shares of Enliven Therapeutics, Inc. (ELVN) stock worth about $3.47M. David Mott is the Director of Mersana Therapeutics, Inc. and owns shares of Mersana Therapeutics, Inc. (MRSN) stock worth about $1.62M. David Mott is the Director of NOVAVAX INC and owns shares of NOVAVAX INC (NVAX) stock worth about $1.09M.
All Insider Reports
All Insider Reports

Ownership of David Mott

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ARDX ARDELYX, INC. Director $6.67M +$997K +17.6% Nov 13, 2024
ELVN Enliven Therapeutics, Inc. Director $3.47M Jun 2, 2022
MRSN Mersana Therapeutics, Inc. Director $1.62M Jun 11, 2024
NVAX NOVAVAX INC Director $1.09M Jun 12, 2024
ADAP Adaptimmune Therapeutics PLC Director Jul 1, 2024
EPZM Epizyme, Inc. Director Aug 12, 2022

Insider Transactions Reported by David Mott:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.